“To Compare the Efficacy and Safety of Rosuvastatin, Atorvastatin and Pravastatin Among Dyslipidemic Diabetic Patients at a Tertiary Centre in Bihar ”. 2023. Journal of Pharmaceutical Negative Results, February, 672-76. https://doi.org/10.47750/pnr.2023.14.03.087.